Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system
article
OA: closed
CC0
⤵ 10 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated how an oral contraceptive with ethinyl estradiol and dienogest impacts the hemostatic system in a double-blind, randomized, placebo-controlled trial.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Der Einfluß von Dienogest auf die Ovulation junger Frauen und auf weitere ausgewählte endokrinologische Parameter via openalex
- doi:10.1097/00019616-199411000-00011 via openalex
- doi:10.1016/0010-7824(95)00271-5 via openalex
- doi:10.1016/0002-9378(90)90595-x via openalex
- doi:10.1016/0010-7824(90)90036-u via openalex
- doi:10.1016/0002-9378(90)90590-4 via openalex
- doi:10.1016/0049-3848(88)90312-x via openalex
- doi:10.1016/0378-5122(88)90023-0 via openalex
- doi:10.1136/bmj.280.6224.1157 via openalex
- doi:10.1111/j.1365-2141.1988.tb04232.x via openalex
- doi:10.1016/0002-9378(90)90594-w via openalex
- doi:10.1055/s-0038-1646497 via openalex
- doi:10.1136/bmj.306.6883.956 via openalex
- W2186866099 via openalex
- W2249810689 via openalex
- W2300692921 via openalex
- W2303726387 via openalex
- W2529428394 via openalex
- W6697879500 via openalex
- doi:10.1016/0010-7824(94)90106-6 via openalex
- doi:10.1093/oxfordjournals.aje.a115799 via openalex
- doi:10.1016/0049-3848(87)90262-3 via openalex
- doi:10.1016/0002-9378(90)90596-y via openalex
- doi:10.1016/1043-2760(94)90064-7 via openalex
- doi:10.1016/0010-7824(89)90116-9 via openalex
- doi:10.1016/s0140-6736(80)91550-0 via openalex
- doi:10.1016/s0002-9378(16)32484-x via openalex
- doi:10.1016/s0002-9378(87)80129-1 via openalex
- doi:10.1136/bmj.2.5703.203 via openalex
- doi:10.1056/nejm198608143150708 via openalex
- doi:10.1016/0010-7824(85)90072-1 via openalex
Cited by (10)
- Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol 2025
- Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill 2010
- Ethinylestradiol/Dienogest in Oral Contraception 2010
- Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters 2008
- Effect of four oral contraceptives on hemostatic parameters 2004
- Progestogens with Antiandrogenic Properties 2003
- THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDY 2000
- The efficacy and tolerability of Valette®: a postmarketing surveillance study 1999
- Clinical profile of Valette® 1999
- Dienogest 1998
Source provenance
- openalex
- last seen: 2026-05-11T06:15:24.675520+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK